Para-nitroazaprocin
![]() | |
Legal status | |
---|---|
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C18H23N3O3 |
Molar mass | 329.400 g·mol−1 |
3D model (JSmol) | |
| |
|
Para-nitroazaprocin is an opioid designer drug which is the 4'-nitro derivative of azaprocin. It has around 25x the potency of morphine,[1] and was made a Class A drug in the UK in May 2024.[2]
References
- ^ Cignarella G, Barlocco D, Tranquillini ME, Volterra A, Brunello N, Racagni G (May 1988). "Interaction of 3,8-diazabicyclo (3.2.1) octanes with mu and delta opioid receptors". Pharmacological Research Communications. 20 (5): 383–394. doi:10.1016/s0031-6989(88)80014-6. hdl:11380/1247742. PMID 2843931.
- ^ "Order 2024". The Misuse of Drugs Act 1971 (Amendment).
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.